• Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Economy
M&A·IB

Inheritance Tax Bill Lands on the Choi Family of Korea Zinc… Will Their Controlling Stake Be Shaken? [Exclusive to Edaily]

An unexpected variable has emerged for the camp of Choi Yoon-beom, Chairman of Korea Zinc, who is currently embroiled in a management control dispute. This is because a relative and senior academic—Pr…
  • 2026-06-17 17:01:03
  • Hur Jieun
Financing

[Market In] From Bad Debts to Borrowing Emergency Funds… Hyundai Engineering & Construction’s Credit Rating Under ‘Warning’ Due to 7.7 Trillion Won in Accounts Receivable

#Hyundai Engineering & Construction has aggressively expanded its overseas operations but is experiencing a slowdown in cash flow due to its inability to collect construction payments on time. Despite…
  • 2026-06-17 16:47:03
  • LEE GEON-EOM
Business·Industry

Dong-A Socio Group to Participate in BIO USA 2026

Dong-A Socio Group will operate a joint booth with Dong-A ST, ST Pharm, and BTGen at the “Bio International Convention 2026” (BIO USA 2026), taking place in San Diego, USA, from the 22nd to the 25th (…
  • 2026-06-17 16:08:02
  • KIM SAE-MI
Financing

[Market In] Clean Nation, Now on the Brink of Speculative Grade, Downgraded to BBB-

#Korea Ratings (KR) announced on the 17th that it had downgraded #Clean Nation’s unsecured corporate bonds and corporate credit rating (ICR) from “BBB (Negative)” to “BBB- (Stable).” The credit rating…
  • 2026-06-17 15:17:02
  • LEE GEON-EOM
Business·Industry

Halozime Finally Abandons UK Patent… Good News for Alteogen? [Exclusive to Edaily]

#It has been confirmed that Altogen’s partner, Merck (MSD), has secured a complete victory in a lawsuit filed in the UK regarding Halozime’s European patent. With Halozime voluntarily revoking its UK …
  • 2026-06-17 14:01:02
  • Kim Jinsoo
Business·Industry

KEPCO Appoints Baek Woo-ki and Jeon Chan-hyuk as New Standing Directors

(From left) Baek Woo-ki and Jeon Chan-hyuk, new standing directors of Korea Electric Power Corporation (KEPCO). #Korea Electric Power Corporation (KEPCO) appointed Baek Woo-ki and Jeon Chan-hyuk a…
  • 2026-06-17 13:20:40
  • Kim Hyung-wook
Business·Industry

Wontech Obtains ‘Lavian’ Medical Device Certification in South Africa… Enters the African Market

#Wontech, a laser and energy-based medical solutions company, is expanding its reach to the African continent after obtaining medical device certification in South Africa for its cosmetic laser device…
  • 2026-06-17 09:53:18
  • YU JIN-HEE
Business·Industry

Penitrium Bio Begins Phase 1 Clinical Trial Combining Its Drug with ‘Keytruda’... Tackling the 137-Year-Old Challenge of Cancer Metastasis

#PenitriumBioScience, which has drawn attention from the global pharmaceutical and biotech industries by elucidating the mechanism of cancer metastasis—a problem that had remained unsolved in oncology…
  • 2026-06-17 09:43:10
  • YU JIN-HEE
Business·Industry

"No College Degree Required"... Job Seekers Flock to SK Hanik's Unconventional Hiring Drive

SK Hynix has decided to completely abolish educational requirements starting with its rolling recruitment for new employees, which begins on the 17th. The company aims to break down educational barrie…
  • 2026-06-17 09:20:40
  • SOYEON KIM
Business·Industry

'Cumulative Technology Transfer Value Reaches 3 Trillion Won': Aimed Bio Sees a Series of ADC Technology Transfers

#AimedBio is drawing attention for achieving a cumulative total of 3 trillion won in technology transfer deals while still in the unlisted and preclinical stages. AimedBio was listed on the KOSDAQ mar…
  • 2026-06-17 08:11:01
  • Lim Jeong-yeo
prev 11 12 13 14 15 16 17 18 19 20 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea
English